Loading...
Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas
The BRAF(V600E) mutation, which in melanoma is targetable with vemurafenib, is also found in sarcomas and we here evaluate the therapeutic potential in sarcoma cell lines. Methods: Four sarcoma cell lines harboring the BRAF(V600E) mutation, representing liposarcomas (SA-4 and SW872), Ewing sarcoma (...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5979358/ https://ncbi.nlm.nih.gov/pubmed/29570692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19040969 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|